Application of Machine Learning for Predicting Progression‐Free and Overall Survival in Patients With Renal Cell Carcinoma

Documenti analoghi

• The IQGAP1 ‐Claudin4‐ JNK Signaling Axis as a Differential Biomarker in Renal Cell Carcinoma
  di: Nahshon Puente, et al.
  Pubblicazione: (2026)
• Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences
  di: Mohamed H. Shahin, et al.
  Pubblicazione: (2025)
• Longitudinal Assessment of Biomarkers in ALS : Discriminative Biomarkers for Disease Progression and Survival
  di: David R. Beers, et al.
  Pubblicazione: (2026)
• Predictive Analysis for First Submission of Generic Drug Application for Orphan Drug Products Using Random Survival Forest
  di: Robert Hopefl, et al.
  Pubblicazione: (2025)
• Application of Machine Learning to Discriminate Photoreceptor Cell Species in Xenotransplanted Chimeric Retinas
  di: Kang V. Li, et al.
  Pubblicazione: (2025)